Author's Perspective ｜ Reproductive Medicine Clinician · Based on frontline clinical workflow
Standard Pathway from Initial Reproductive Center Visit to Completing Pre-IVF Examinations
In a reproductive medicine center, pre-IVF examinations are the first step toward starting IVF treatment. After the couple registers and completes the initial consultation, the doctor will prescribe a complete set of pre-treatment tests. These tests cover fertility assessment for both partners, infectious disease screening, genetic screening, and overall health evaluation. The entire process typically takes 4 to 6 weeks, depending on the patient's menstrual cycle schedule, the completeness of the tests, and whether any abnormal results require follow-up or referral.
Core Principle: Pre-IVF examinations are not completed all at once but are scheduled in phases based on the menstrual cycle, abstinence period, and the nature of the tests. Understanding the process in advance can effectively reduce the number of visits and shorten the overall preparation time.
Female Examination Checklist and Timing
Female examinations are divided into three categories: menstrual phase tests, non-menstrual phase tests, and tests that can be done anytime. Each category has specific time windows.
Menstrual Cycle Days 2-4: Baseline Endocrine and Ovarian Reserve Assessment
- Sex Hormone Panel (6 items): FSH, LH, E2, P, T, PRL. Used to assess ovarian reserve, ovulation status, and endocrine environment.
- Anti-Müllerian Hormone (AMH): A sensitive indicator of ovarian reserve, unaffected by the menstrual cycle, but usually ordered alongside the sex hormone panel.
- Antral Follicle Count (AFC): Transvaginal ultrasound to count antral follicles (2-9mm) in both ovaries, a direct imaging indicator of ovarian reserve.
Why this time? The early menstrual phase provides the clearest window into the baseline ovarian state. Hormone levels at this time accurately reflect the functional baseline of the ovaries, avoiding interference from luteal phase or post-ovulation hormonal fluctuations.
3-7 Days After Menstruation Ends: Uterine Cavity and Fallopian Tube Assessment
- Hysteroscopy: Direct visualization of the uterine cavity and endometrial condition to check for polyps, adhesions, fibroids, or abnormalities that could affect embryo implantation.
- Hysterosalpingography (HSG): Evaluates tubal patency and fimbrial function. Especially important for those with a history of pelvic inflammatory disease, ectopic pregnancy, or previous abdominal surgery.
Precautions: Avoid intercourse and vaginal medications for 3 days before the tests. Some patients may need a short course of antibiotics afterward to prevent infection.
Tests That Can Be Done Anytime (No Time Restrictions)
- Infectious disease screening: Hepatitis B panel (5 items), Hepatitis C antibody, HIV antibody, Syphilis serology (RPR/TPPA)
- Chromosome karyotype analysis (peripheral blood)
- Coagulation profile (4 items), Complete blood count (CBC), Liver and kidney function, Fasting blood glucose, Thyroid function (TSH, FT3, FT4)
- Blood type (ABO+Rh), TORCH panel (5 items)
- Electrocardiogram (ECG), Chest X-ray (for those planning pregnancy, confirm non-pregnant status before X-ray)
These tests do not need to be coordinated with the menstrual cycle and can be scheduled on any workday. It is recommended to schedule them on the same day as the menstrual phase tests to reduce the number of visits.
Male Examination Checklist and Requirements
Male examinations are relatively concentrated, but semen analysis has strict abstinence requirements and is a key step that needs advance planning.
Semen Analysis (Core Test)
- Abstinence Period: 2-7 days, with 3-5 days being optimal. Too short or too long an abstinence period can affect the accuracy of sperm density, motility, and morphology assessment.
- Test Content: Semen volume, pH, sperm concentration, percentage of progressively motile sperm, percentage of normal morphology, sperm DNA fragmentation index (DFI, routinely performed in some centers).
- Repeat Testing Principle: If the first result is abnormal, it is recommended to repeat the test after an interval of 2-4 weeks, obtaining 2-3 consistent values for clinical reference.
Other Routine Tests
- Infectious disease screening (same as for the female partner, identical items)
- Chromosome karyotype analysis
- Blood type, Liver and kidney function, Coagulation profile
- Some centers add Y-chromosome microdeletion (AZF) screening, indicated for patients with azoospermia or severe oligoasthenoteratozoospermia
Doctor's Advice: Male examinations are generally quicker, but semen analysis is sensitive to the abstinence period. It is recommended to start tracking the abstinence days 3 days before the planned test to avoid invalid results or needing to reschedule due to incorrect timing.
Validity Periods of Test Results and Repeat Testing Rules
The validity periods of different tests vary significantly. Properly scheduling the tests can avoid repeat testing due to expired results.
| Test Item | Validity Period | Notes |
|---|---|---|
| Infectious disease screening (Hepatitis B, C, HIV, Syphilis) | 6 months | Some centers require 3 months; follow the specific hospital's policy |
| Chromosome karyotype analysis | Lifetime | Abnormal results require genetic counseling but do not affect validity |
| Semen analysis | 3-6 months | Abstinence period must meet requirements; repeat if abnormal |
| Sex hormone panel + AMH | 3-6 months | For age >38 or diminished ovarian reserve, recommend validity within 3 months |
| Liver/kidney function, Coagulation, CBC | 3-6 months | Those with underlying conditions need adjusted repeat frequency based on disease status |
| Hysteroscopy / HSG | 6-12 months | Re-evaluation needed if uterine instrumentation or pelvic infection occurs during this period |
| Chest X-ray, ECG | 6-12 months | Abnormal results require specialist assessment before proceeding with the cycle |
From a scheduling perspective, it is advisable to prioritize chromosome testing (lifetime validity) and infectious disease screening (shorter validity, can be done within 3 months before starting the cycle). Semen analysis and hormone tests should be scheduled closer to the time of filing the medical record to ensure results cover the entire treatment cycle.
Differences Between Reproductive Centers
Although the National Health Commission's "Technical Standards for Human Assisted Reproductive Technology" provides basic requirements for pre-IVF examinations, there are some differences in implementation across centers.
- Basic Tests: All centers with IVF qualifications require the core items listed above (sex hormones, AMH, infectious diseases, chromosomes, semen analysis, etc.).
- Advanced Tests: Some centers routinely include: sperm DNA fragmentation index, endometrial microbiome testing, immune-related infertility antibodies (anti-sperm antibodies, anti-endometrial antibodies, etc.), vitamin D levels, HLA compatibility testing. These are not mandatory, but doctors may recommend them based on age, history of previous failure, or specific etiology.
- Recognition of External Results: Most centers accept test results from tertiary hospitals (within validity), but some require re-verification of key items (e.g., infectious diseases, chromosomes) at their own facility. It is advisable to confirm the result recognition policy with your target reproductive center beforehand to avoid repeat testing.
How Doctors Interpret Pre-IVF Test Results
The core purpose of pre-IVF examinations is to identify risk factors affecting success rates or pregnancy safety, not simply to assess "whether IVF is possible." Doctors focus on the following aspects:
- Ovarian Reserve and Responsiveness: Combined assessment of AMH + AFC + FSH to determine the ovarian response type (normal, poor, or high) to ovulation induction medications, enabling individualized treatment protocols.
- Uterine Environment: Findings from hysteroscopy, such as endometrial polyps, adhesions, or submucosal fibroids, need treatment before embryo transfer, as they can reduce implantation rates or increase miscarriage risk.
- Genetic Risk: Chromosomal structural abnormalities (e.g., balanced translocation, Robertsonian translocation) or carriers of single-gene disorders require evaluation for preimplantation genetic testing (PGT).
- Infection Risk: Active Hepatitis B, Syphilis, or HIV infection requires joint management by infectious disease and reproductive specialists to develop a mother-to-child transmission prevention plan before starting the cycle.
Clinical Experience: The purpose of pre-IVF examinations is not to "screen out who cannot do IVF," but to determine "how to do IVF more safely and effectively." The vast majority of abnormal results have corresponding management strategies. The proportion of patients directly denied a cycle due to test results is less than 5%.
Easily Overlooked Details
Based on observations from frontline practitioners, the following details are often overlooked during the preparation phase, potentially causing delays or requiring repeat tests:
- Document Preparation: Original and copies of both partners' ID cards and marriage certificate. Some centers require household registration books or certificates; it is advisable to call ahead to confirm.
- Past Medical History Records: Previous surgical records, pathology reports, and external test results (especially hysteroscopy and laparoscopy reports). These help the doctor fully assess the condition and avoid unnecessary invasive procedures.
- Medication Record: Long-term medications (e.g., antihypertensives, anticoagulants, psychotropic drugs, traditional Chinese medicine, supplements) must be disclosed to the doctor. Some medications may need adjustment or discontinuation before testing.
- Menstrual Cycle Record: During the initial consultation, the doctor will ask about the last menstrual period, cycle length, and regularity. Recording 3-6 months of menstrual cycles in advance helps the doctor assess endocrine status.
- Abstinence Time Management: The abstinence period for the male semen analysis needs to be precise to the day. It is advisable to confirm the specific date when scheduling and set a reminder.
Risk Reminder: If test results are abnormal (e.g., thyroid dysfunction, high blood sugar, abnormal liver function), do not rush into starting the cycle. First, complete consultations and treatment with the relevant specialists. Entering a cycle with uncontrolled metabolic abnormalities may increase the risk of ovulation induction complications or affect embryo quality.
Sample Timeline for Pre-IVF Examinations
Below is a typical schedule reference for a patient with a regular menstrual cycle (28-30 days):
| Time Point | Female Tests Completed | Male Tests Completed |
|---|---|---|
| Menstrual cycle days 2-4 | Sex hormone panel (6 items), AMH, Antral follicle count | — |
| 3-5 days after menstruation ends | Hysteroscopy (HSG if necessary) | — |
| Any day during the cycle (can be same day as above) | Infectious disease screening, Chromosomes, Blood type, Coagulation, Liver/kidney function, Thyroid function, ECG, Chest X-ray | Infectious disease screening, Chromosomes, Blood type, Coagulation, Liver/kidney function |
| After 3-5 days of abstinence | — | Semen analysis + Sperm DNA fragmentation index (if needed) |
| After all results are available (approx. 2-4 weeks) | Return to reproductive center to file medical record; doctor reviews results and develops ovulation induction protocol | |
If the patient is over 38 years old, has AMH <1.2 ng/mL, or has a history of previous IVF failure, the doctor may add hysteroscopy or immune-related tests before the cycle, requiring an additional 1-2 weeks.
Special Considerations for Specific Groups
Advanced Maternal Age (≥38 years)
Ovarian reserve assessment is key, with AMH and AFC being critical indicators of follicle count. Additionally, the risk of chromosomal aneuploidy increases with age. Some centers may recommend preimplantation genetic testing for aneuploidy (PGT-A), and genetic counseling should be included in the pre-IVF workup.
History of Recurrent Miscarriage (≥2 times)
Requires additional testing: chromosome karyotype analysis for both partners, uterine cavity assessment, thrombophilia screening, and immune-related tests. For those with recurrent implantation failure, consider endometrial receptivity analysis (ERA) and chronic endometritis evaluation.
Underlying Medical Conditions (Diabetes, Hypertension, Autoimmune Diseases)
Requires specialist evaluation of disease stability and a written opinion confirming fitness for pregnancy. Additional tests (e.g., HbA1c, urine protein, antinuclear antibody panel) may be needed based on the primary condition.
Male Factor (Azoospermia, Severe Oligoasthenoteratozoospermia)
In addition to standard semen analysis, requires reproductive hormone testing (FSH, LH, T), Y-chromosome microdeletion screening, and testicular or epididymal sperm aspiration evaluation. These results determine whether intracytoplasmic sperm injection (ICSI) or donor sperm is needed.
Doctor's Advice: Pre-IVF examinations for special groups are not a "one-size-fits-all" package but a step-by-step investigation based on individual conditions. Do not be overly anxious about a single abnormal result; most issues have corresponding solutions.
Frequently Asked Questions About Pre-IVF Examinations
- Q: Can I still do IVF if my AMH is low?
Yes. Low AMH does not mean no usable embryos can be obtained; it indicates a limited number of follicles. A tailored ovulation induction protocol (e.g., mild stimulation, natural cycle, or luteal phase stimulation) is needed, along with realistic expectations. - Q: What if the chromosome test is abnormal?
Carriers of structural chromosomal abnormalities (e.g., balanced translocation) can use PGT to select embryos that are normal or balanced carriers for transfer. Numerical abnormalities (e.g., 45,X/46,XX mosaicism) require genetic counseling to assess genetic risk before deciding on a cycle. - Q: Can I still do IVF if I test positive for an infectious disease?
Infectious diseases like Hepatitis B, Syphilis, and HIV are not absolute contraindications for IVF, but they require joint management by infectious disease and reproductive specialists. Appropriate protective measures and mother-to-child transmission prevention strategies must be implemented during the treatment cycle. - Q: Can I use test results from another hospital?
Results from tertiary hospitals (within their validity period) are accepted by most reproductive centers, but some centers require re-verification of key items (e.g., infectious diseases, chromosomes). It is advisable to confirm the result recognition policy with your target center in advance.
Practitioner Observation: Most Common Causes of Delays in the Pre-IVF Examination Phase
According to clinical frontline statistics, the pre-IVF examination phase takes an average of 1.5 months, with about 30% of patients experiencing unplanned delays due to the following reasons:
- Irregular menstrual cycles causing misalignment of the hormone test window (accounts for ~35% of delays)
- Male abstinence period not meeting requirements, necessitating rescheduling of semen analysis (25%)
- Incomplete external test results or format not meeting center requirements (20%)
- Abnormal findings requiring specialist referral (15%)
- Incomplete documents or information (5%)
Understanding these "bottlenecks" in advance and taking targeted steps to avoid them can shorten the overall preparation time to 3-4 weeks.
Time Planning Reminder: Completing the pre-IVF examinations is not the end point but the starting point for entering the treatment cycle. It is recommended to simultaneously prepare documents, organize medical records, and engage in psychological preparation during the testing phase to be fully ready for the subsequent ovulation induction, egg retrieval, and embryo transfer stages.
Comments (0)